The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pa...
The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathology
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
While amyloid-β protein (Aβ) aggregation into insoluble plaques is one of the pathological hallmarks of Alzheimer’s disease (AD), soluble oligomeric Aβ has been hypothesized to be responsible for synapse damage, neurodegeneration, learning, and memory deficits in AD. Here, we investigate the
in vitro
and
in vivo
efficacy of the
d
...
Alternative Titles
Full title
The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathology
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5701182
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5701182
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-017-16565-1
